[ Morning Stock Screener ] These 6 Tickers are looking Strong

This is a must read. If you cannot see this email properly, please click [here]( Sponsor [Is This The Most Overlooked Gold Investment Strategy of 2024?]( [Read this stunning report on a little-known gold royalty investment strategy]( --------------------------------------------------------------- Dear Reader, We just ran our screens and wanted to point out 6 'Strong Buy' Stocks that you might want to keep an eye on....Keep in mind, these are very volatile stocks so please do your own research before you make any investments. We are not recommending these stocks. See the list below. --------------------------------------------------------------- Sponsor [Is Gold Really Boring?]( investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. [See why this could be a huge untapped gold investing opportunity.]( --------------------------------------------------------------- [Micron Technology, Inc., MU]( - Buy to Strong Buy Our research shows that [Micron Technology, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $103.40. The target pricing ranges from a high forecast of $95 down to a low forecast of $105. [Micron Technology, Inc. (MU)](’s last closing price was $98.06 which would put the average price target at 5.45% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy - Yahoo! Finance: Bearish - Barchart.com: Strong buy [Click for chart >>]( [Mind Medicine (MindMed) Inc., MNMD]( - Buy to Strong Buy Our research shows that [Mind Medicine (MindMed) Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $26.40. The target pricing ranges from a high forecast of $9 down to a low forecast of $15. [Mind Medicine (MindMed) Inc. (MNMD)](’s last closing price was $8.20 which would put the average price target at 221.95% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy - Yahoo! Finance: Bearish - Barchart.com: Strong buy [Click for chart >>]( --------------------------------------------------------------- Sponsor [Turn market chaos into your #1 advantage]( t let market volatility erode your hard-earned savings. Our free gold guide shows you how to thrive in turbulent markets. So the more volatile markets become… or the dollar struggles… or inflation soars… the more secure your retirement becomes. It’s time to take charge of your wealth. Download our free guide to see how to turn your 401k into a gold IRA and protect your retirement today. [Download your free gold guide now]( --------------------------------------------------------------- [MetLife, Inc., MET]( - Buy to Strong Buy Our research shows that [MetLife, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $81.40. The target pricing ranges from a high forecast of $86 down to a low forecast of $78. [MetLife, Inc. (MET)](’s last closing price was $71.69 which would put the average price target at 13.54% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy - Yahoo! Finance: Bullish - Barchart.com: Strong buy [Click for chart >>]( [MediaAlpha, Inc., MAX]( - Buy to Strong Buy Our research shows that [MediaAlpha, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $20.40. The target pricing ranges from a high forecast of $28 down to a low forecast of $18. [MediaAlpha, Inc. (MAX)](’s last closing price was $21.86 which would put the average price target at -6.68% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy - Yahoo! Finance: Neutral - Barchart.com: Strong buy [Click for chart >>]( --------------------------------------------------------------- Sponsor [#1 Stock for Energy Crisis (Buy Now for Just $8)]( the world suffers an oil shock… And gas prices rip higher… One tiny company could have the answer to the global energy crisis. It’s using AI to crack open the largest untapped energy source on the planet… 5X larger than the biggest oil field on Earth. [Act fast, this $8 stock could be moments away from appreciating considerably.]( --------------------------------------------------------------- [Leidos Holdings, Inc., LDOS]( - Buy to Strong Buy Our research shows that [Leidos Holdings, Inc.]( currently has 5 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $140.20. The target pricing ranges from a high forecast of $145 down to a low forecast of $130. [Leidos Holdings, Inc. (LDOS)](’s last closing price was $129.56 which would put the average price target at 8.21% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy - Yahoo! Finance: Bullish - Barchart.com: Strong buy [Click for chart >>]( [Kura Oncology, Inc., KURA]( - Buy to Strong Buy Our research shows that [Kura Oncology, Inc.]( currently has 4 analysts offering 12-month price targets and the consensus is a Buy rating with an average price target is $29.75. The target pricing ranges from a high forecast of $33 down to a low forecast of $22. [Kura Oncology, Inc. (KURA)](’s last closing price was $22.86 which would put the average price target at 30.14% upside. Other 3rd party rating services are showing the following: - TipRanks.com: Buy - Yahoo! Finance: Bullish - Barchart.com: Strong buy [Click for chart >>]( --------------------------------------------------------------- Sponsor [Game-Changing Cancer Tech Nears FDA Completion]( the world of tech advancements, a new player could outshine even AI. It's a revolutionary technology with the aim of transforming cancer detection. Imagine the leap from basic reading glasses to cutting-edge VR; that's the scale of innovation we're talking about. FDA review is in its final stages and it could become the gold standard before we know it. [Explore Investment Opportunities in This Market Disruptor]( --------------------------------------------------------------- Pricing & Percentages as of approximately 10:00am EST. To your financial freedom! The Editor MarketSectorDaily.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. [If you are not a human, click here.]( This is part of your free subscription to MarketSectorDaily.com MarketSectorDaily.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Mt. Mourne | North Carolina | 28123 | United States | 8774119808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software